miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways

Patients with inflammatory bowel disease are at increased risk for colitis-associated colorectal cancer (CAC). Therefore, controlling intestinal inflammation is a key therapeutic strategy for CAC. MicroRNAs (miRNAs or miRs) are a family of small noncoding RNAs that have the capacity to regulate fund...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Wei Zhang, Xianghui Fu, Jiansheng Xie, Hongming Pan, Weidong Han, Wendong Huang
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2021-06-01
Rangatū:	Molecular Therapy: Nucleic Acids
Ngā marau:	MiR-26a Intestinal inflammation Colitis-associated carcinogenesis NF-κB/STAT3 Macrophage
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2162253121000640
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways

Ngā tūemi rite